Buy Levemir FlexTouch Online

(Insulin Detemir)

The active ingredient in Levemir FlexTouch is insulin detemir.

Insulin detemir is a long-acting insulin that works by helping glucose move from the bloodstream into the body’s cells, where it is used for energy. It also reduces the amount of glucose made by the liver. Its long duration of action comes from its ability to bind to proteins in the bloodstream, which allows it to be released slowly over time. This helps maintain steady blood sugar levels throughout the day and night.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide before using Levemir FlexTouch. However, the following is a synopsis of the general guidelines for the use of Levemir FlexTouch:

• Inject Levemir FlexTouch subcutaneously under the skin as directed by your healthcare provider.
• Common injection site areas include the upper arm, thigh, or abdomen.
• Rotate injection sites to reduce the risk of lipodystrophy.
• It may be used once daily or twice daily, depending on your dose of insulin and treatment plan. If you use the medicine twice daily, use your evening dose at least 12 hours after your morning dose.
• Use the prefilled pen with compatible needles such as NovoFine.
• Do not mix Levemir with other insulin products in the same syringe.
• Regular blood glucose monitoring is an important part of your treatment.
• If you miss a dose, contact your healthcare provider for guidance on the next dose.

Some mild or common side effects of Levemir FlexTouch include:

• Low blood sugar (hypoglycemia).
• Injection site reactions such as redness or irritation.
• Weight gain.
• Swelling or fluid retention.
• Headache.
• Blurred vision.
• Drowsiness.

Some individuals may experience serious side effects while using Levemir FlexTouch. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Severe hypoglycemia, which can be life-threatening.
• Signs of allergic reactions such as hives, trouble breathing, or swelling.
• Low potassium levels (hypokalemia).
• Heart failure symptoms when used with certain diabetes medications, such as thiazolidinediones.
• Fast heartbeat or irregular heart rhythm.

These are not all of the possible side effects of Levemir FlexTouch. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Levemir FlexTouch, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including if you have:

• Episodes of hypoglycemia or low blood sugar.
• Edema.
• Kidney or liver disease.
• Heart failure or other heart conditions.
• Low potassium levels.
• Diabetic ketoacidosis.

Additional precautions:

• Levemir FlexTouch should not be used during episodes of hypoglycemia.
• Monitor blood sugar levels closely when starting or changing your dose.
• Changes in diet, body weight, or activity level may affect your insulin needs.
• Use caution when driving or operating machinery if you have symptoms of low blood sugar.
• Always follow your healthcare provider’s instructions for your insulin regimen.

Levemir FlexTouch should not be used in the following situations:

• During episodes of hypoglycemia.
• Known hypersensitivity or allergic reaction to insulin detemir or any of its components.

Levemir FlexTouch begins to work within a few hours after injection. Its long-acting insulin effect helps control blood sugar levels over an extended period, often lasting up to 24 hours, depending on the dose and individual response.

When Levemir FlexTouch is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• Thiazolidinediones, which may increase the risk of fluid retention and heart failure when used with insulin.
• Other antidiabetic medications such as liraglutide, metformin, and GLP-1 receptor agonist, which may affect blood glucose control.

Levemir FlexTouch is available as a prefilled insulin pen.

• Typically contains 100 units of insulin detemir per mL.
• Doses are measured in units of insulin and adjusted individually.
• The starting dose of Levemir in patients with type 1 diabetes should be approximately one-third of the total daily insulin requirements.

Unopened pens should be stored in the refrigerator. Do not freeze insulin.

Once in use, the pen may be kept at room temperature for a limited time as directed. Keep away from direct heat and light. Keep out of the reach of children.

Levemir FlexTouch is manufactured by Novo Nordisk.

No, there is no generic version of Levemir FlexTouch currently available.

Do not stop taking Levemir FlexTouch without consulting your healthcare provider.

• Stopping insulin suddenly can lead to high blood sugar or diabetic ketoacidosis.
• Your healthcare provider may adjust your insulin regimen or switch you to another type of insulin if needed.

Levemir FlexTouch (insulin detemir) can generally be used during pregnancy. It is considered safe for use in pregnant women with type 1, type 2, or gestational diabetes, and is often used to manage blood sugar levels during this time.

Levemir FlexTouch (insulin detemir) can generally be used while breastfeeding, but you must consult your doctor to adjust your dose.